3 days ago
JAZZ
AnalystsGregory RenzaGregory Renza's Stock Forecasts
AnalystsGregory Renza
Analyst Ranking
Top 3%
#111 out of 5500 analysts
Average Return
+23.13%
Win Rate
50%148 out of 294
Risk vs Reward
Poor
Good
Gregory Renza's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Cidara Therapeutics IncCDTX | +1,088.30% | $18.63 | $221.38 | 2025-05-09 - 2026-01-06 | Buy |
Cidara Therapeutics IncCDTX | +864.38% | $22.88 | $220.65 | 2024-12-13 - 2025-12-12 | Buy |
Cidara Therapeutics IncCDTX | +811.78% | $24.28 | $221.38 | 2025-05-23 - 2026-01-06 | Buy |
Prometheus Biosciences IncRXDX | +603.13% | $27.52 | $193.50 | 2022-05-13 - 2023-04-18 | Buy |
Alpine Immune Sciences IncALPN | +428.30% | $12.19 | $64.40 | 2023-10-05 - 2024-04-11 | Buy |
Gregory Renza Analyst Color
Get additional color on Gregory Renza's coverage of popular stocks
18 days ago
RVMD
22 days ago
ZYME
23 days ago
ONC
25 days ago
JAZZ
2 months ago
NRIX
2 months ago
ZYME
2 months ago
ONC
2 months ago
ABVX
2 months ago
VRDN
2 months ago
RVMD
3 months ago
NRIX
3 months ago
RVMD
4 months ago
CGON
4 months ago
GILD
6 months ago
ONC
7 months ago
GILD
7 months ago
CGON
7 months ago
GILD
8 months ago
CGON
8 months ago
IDYA
9 months ago
CATX
9 months ago
NRIX
9 months ago
GILD
9 months ago
ONC
Gregory Renza's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Revolution Medicines IncRVMD | 4 | Strong Buy | $239.00 | +14.97% | Maintains | 2 days ago |
Jazz Pharmaceuticals PLCJAZZ | 17 | Strong Buy | $281.00 | +14.91% | Maintains | 3 days ago |
Zymeworks IncZYME | 2 | Strong Buy | $32.00 | +13.19% | Maintains | 22 days ago |
Viridian Therapeutics IncVRDN | 16 | Strong Buy | $39.00 | +68.98% | Maintains | 22 days ago |
Cg Oncology IncCGON | 9 | Strong Buy | $85.00 | +14.34% | Maintains | 22 days ago |
Exelixis IncEXEL | 14 | Hold | $52.00 | -4.50% | Maintains | 23 days ago |
Beone Medicines LtdONC | 7 | Strong Buy | $418.00 | +13.98% | Maintains | 23 days ago |
Ideaya Biosciences IncIDYA | 16 | Strong Buy | $59.00 | +47.10% | Maintains | 24 days ago |
Amgen IncAMGN | 22 | Hold | $362.00 | -16.29% | Maintains | 24 days ago |
Regeneron Pharmaceuticals IncREGN | 8 | Strong Buy | $772.00 | -2.79% | Maintains | a month ago |
Agios Pharmaceuticals IncAGIO | 11 | Strong Buy | $39.00 | +17.05% | Maintains | a month ago |
Nurix Therapeutics IncNRIX | 14 | Strong Buy | $34.00 | +29.72% | Maintains | 2 months ago |
Xencor IncXNCR | 11 | Strong Buy | $27.00 | +3.61% | Maintains | 2 months ago |
Nuvation Bio IncNUVB | 8 | Strong Buy | $13.00 | +95.20% | Maintains | 2 months ago |
Gilead Sciences IncGILD | 5 | Strong Buy | $156.00 | +7.08% | Maintains | 2 months ago |
Abivax SaABVX | 3 | Strong Buy | $155.00 | +36.74% | Maintains | 2 months ago |
Nuvalent IncNUVL | 2 | Hold | $124.00 | +0.03% | Downgrades | 3 months ago |
Fulcrum Therapeutics IncFULC | 6 | Hold | $4.00 | +3.90% | Downgrades | 3 months ago |
Perspective Therapeutics IncCATX | 7 | Strong Buy | $12.00 | +285.85% | Assumes | 9 months ago |
Mannkind CorpMNKD | 2 | Strong Buy | $9.00 | +127.85% | Initiates Coverage On | 9 months ago |
Bicycle Therapeutics PLCBCYC | 4 | Hold | $10.00 | +138.10% | Initiates Coverage On | 9 months ago |
Ascentage Pharma Group InternationalAAPG | 1 | Strong Buy | $51.00 | +179.05% | Initiates Coverage On | 9 months ago |
Cidara Therapeutics IncCDTX | 3 | Buy | $35.00 | N/A | Maintains | a year ago |
Acadia Pharmaceuticals IncACAD | 14 | Buy | $26.00 | N/A | Reiterates | a year ago |
Adc Therapeutics SaADCT | 12 | Buy | $8.00 | N/A | Reiterates | a year ago |
Inovio Pharmaceuticals IncINO | 11 | Hold | $5.00 | N/A | Reiterates | a year ago |
Spruce Biosciences IncSPRB | 13 | Hold | $0.50 | N/A | Maintains | a year ago |
Cormedix IncCRMD | 6 | Buy | $12.00 | N/A | Reiterates | a year ago |
Verastem IncVSTM | 10 | Buy | $14.00 | N/A | Maintains | a year ago |
Pacira Biosciences IncPCRX | 11 | Hold | $18.00 | N/A | Reiterates | 2 years ago |
Jasper Therapeutics IncJSPR | 4 | Buy | $48.00 | N/A | Maintains | 2 years ago |
Viracta Therapeutics IncVIRX | 8 | Buy | $2.00 | N/A | Maintains | 2 years ago |
Verrica Pharmaceuticals IncVRCA | 7 | Hold | $20.00 | N/A | Downgrades | 2 years ago |
Atyr Pharma IncATYR | 7 | Buy | $16.00 | N/A | Reiterates | 2 years ago |
Morphic Holding IncMORF | 7 | Hold | $57.00 | N/A | Reiterates | 2 years ago |
Alpine Immune Sciences IncALPN | 4 | Hold | $65.00 | N/A | Downgrades | 2 years ago |
Fusion Pharmaceuticals IncFUSN | 3 | Hold | $21.00 | N/A | Downgrades | 2 years ago |
Aptose Biosciences IncAPTOF | 7 | Buy | $540.00 | N/A | Maintains | 3 years ago |
Avalo Therapeutics IncAVTX | 4 | Hold | $180.00 | N/A | Downgrades | 3 years ago |
Bellus Health IncBLU | 8 | Hold | $14.75 | N/A | Reiterates | 3 years ago |
Prometheus Biosciences IncRXDX | 6 | Hold | $200.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 5 | Buy | $229.00 | N/A | Maintains | 3 years ago |
Global Blood Therapeutics IncGBT | 3 | Hold | $68.50 | N/A | Downgrades | 4 years ago |
Aprea Therapeutics IncAPRE | 5 | Hold | $80.00 | N/A | Maintains | 4 years ago |
Provention Bio IncPRVB | 2 | Hold | $10.00 | N/A | Downgrades | 5 years ago |
Iterum Therapeutics PLCITRMF | 3 | Hold | $30.00 | N/A | Downgrades | 6 years ago |
Portola Pharmaceuticals IncPTLA | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Arqule IncARQL | 1 | Hold | $20.00 | N/A | Downgrades | 7 years ago |
Gamida Cell LtdGMDAQ | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.